查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423921

腫瘤學人工智慧市場、份額、規模、趨勢、產業分析報告：按癌症類型、成分、治療類型、地區和細分市場預測，2024-2032年

AI in oncology Market Share, Size, Trends, Industry Analysis Report, By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Treatment Type, By Region, And Segment Forecasts, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球腫瘤人工智慧市場預計將達到 167.2 億美元。 該報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於癌症發生率上升，預計市場將大幅增長，從而推動對用於癌症診斷、治療和分析的技術先進產品的需求。 例如，國際癌症研究機構（IARC）預測，2023年新增病例將超過2,070萬例。 此外，人工智慧在早期檢測和降低死亡率方面發揮著重要作用，特別是透過有效的篩檢計畫。

人工智慧與深度學習和高效能運算的進步相結合，利用多組學分析產生的大量數據集正在徹底改變腫瘤學領域。 人工智慧與腫瘤學的整合涵蓋了癌症管理各個階段的新方法，包括癌症檢測、篩檢、診斷和分類。 人工智慧正在幫助表徵癌症基因組學、分析腫瘤微環境、評估預後和預測生物標誌物，並制定後續護理和藥物發現策略。 人工智慧的綜合應用正在提高癌症研究和治療的精度和效率。

技術的快速進步，特別是在準確性、安全性和自動化方面，預計將在可預見的未來推動市場成長。 作為一種新的變革性技術，人工智慧在顯著提高腫瘤篩檢率方面發揮關鍵作用。 因此，公共和私營部門都將重點放在資助和大力投資研發（R＆D）計劃上，以推動基於人工智慧的腫瘤篩檢產品。

例如，2023年3月，Altera獲得9,000萬美元融資。 這筆資金將支持 ArteraAI 前列腺測試的啟動和商業化，這是第一個用於預測局部前列腺癌治療結果的測試，這是一個重要的裡程碑。 這表明人們對腫瘤學領域創新的人工智慧驅動解決方案的認識和支持不斷增強，這些解決方案有可能提高篩檢效率和治療決策。

該行業的主要參與者策略性地專注於開發創新產品，以促進癌症的早期診斷、滿足不斷增長的需求並推進其研發管線。我們正在致力於建立合作夥伴關係和聯合研究。 例如，2022年12月，阿斯特捷利康開始與Clinicalink合作推出專注於肺癌的AI計畫。 該計畫的主要目標是早期發現肺癌，有助於制定更有效的治療策略。

腫瘤學人工智慧市場報告亮點

軟體解決方案產業佔據最大份額，主要是由於採用基於人工智慧的服務來改善臨床結果。

由於腦腫瘤病例數量不斷增加和巨大的未滿足的醫療需求，腦腫瘤領域預計將增長最快

該市場以北美為主，因為它擁有豐富的醫療基礎設施，並且有提供醫療解決方案的人工智慧玩家。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章研究方法

第 4 章腫瘤學領域的全球人工智慧市場洞察

  • 腫瘤學人工智慧市場 - 治療類型概覽
  • 腫瘤學人工智慧市場動態
    • 促進因素和機會
      • 癌症發生率上升
      • 治療優化
    • 抑制因素和挑戰
      • 資料隱私與安全問題
  • PESTEL 分析
  • 腫瘤人工智慧市場、治療類型趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第 5 章全球腫瘤 AI 市場（以癌症類型）

  • 主要發現
  • 簡介
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 大腸癌
  • 腦腫瘤
  • 其他

第 6 章按組成部分劃分的全球腫瘤人工智慧市場

  • 主要發現
  • 簡介
  • 軟體解決方案
  • 硬體
  • 服務

第 7 章按治療類型劃分的全球腫瘤人工智慧市場

  • 主要發現
  • 簡介
  • 化療
  • 放射治療
  • 免疫治療
  • 其他

第 8 章全球腫瘤學人工智慧市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年腫瘤學人工智慧市場評估（按地區）
  • 腫瘤學人工智慧市場 - 北美
    • 北美：腫瘤人工智慧市場，按癌症類型，2019-2032 年
    • 北美：腫瘤人工智慧市場，依治療類型，2019-2032 年
    • 北美：腫瘤人工智慧市場，按組成部分，2019-2032 年
    • 腫瘤學人工智慧市場 - 美國
    • 腫瘤學人工智慧市場 - 加拿大
  • 腫瘤學人工智慧市場 - 歐洲
    • 歐洲：腫瘤人工智慧市場，按癌症類型，2019-2032 年
    • 歐洲：腫瘤學人工智慧市場，按治療類型，2019-2032 年
    • 歐洲：腫瘤學人工智慧市場，按組成部分，2019-2032 年
    • 腫瘤學人工智慧市場 - 英國
    • 腫瘤學人工智慧市場 - 法國
    • 腫瘤學人工智慧市場 - 德國
    • 腫瘤學人工智慧市場 - 義大利
    • 腫瘤學人工智慧市場 - 西班牙
    • 腫瘤學人工智慧市場 - 荷蘭
    • 腫瘤學人工智慧市場 - 俄羅斯
  • 腫瘤學人工智慧市場 - 亞太地區
      亞太地區：腫瘤學人工智慧市場，按癌症類型，2019-2032 年
    • 亞太地區：腫瘤學人工智慧市場，按治療類型，2019-2032 年
    • 亞太地區：腫瘤學人工智慧市場，按組成部分，2019-2032 年
    • 腫瘤學人工智慧市場 - 中國
    • 腫瘤學人工智慧市場 - 印度
    • 腫瘤學人工智慧市場 - 馬來西亞
    • 腫瘤學人工智慧市場 - 日本
    • 腫瘤學人工智慧市場 - 印尼
    • 韓國腫瘤學人工智慧市場
  • 腫瘤學人工智慧市場 - 中東和非洲
    • 中東和非洲：腫瘤學人工智慧市場，按癌症類型，2019-2032 年
    • 中東和非洲：腫瘤學人工智慧市場，按治療類型，2019-2032 年
    • 中東和非洲：腫瘤學人工智慧市場，按組成部分，2019-2032 年
    • 腫瘤學人工智慧市場 - 沙烏地阿拉伯
    • 腫瘤學人工智慧市場 - 阿聯酋
    • 腫瘤學人工智慧市場 - 以色列
    • 腫瘤學人工智慧市場 - 南非
  • 腫瘤學人工智慧市場 - 拉丁美洲
    • 拉丁美洲：腫瘤人工智慧市場，按癌症類型，2019-2032 年
    • 拉丁美洲：腫瘤人工智慧市場，依治療類型，2019-2032 年
    • 拉丁美洲：腫瘤人工智慧市場，按組成部分，2019-2032 年
    • 腫瘤學人工智慧市場 - 墨西哥
    • 腫瘤學人工智慧市場 - 巴西
    • 腫瘤學人工智慧市場 - 阿根廷

第 9 章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 10 章公司簡介

  • Azra AI
  • IBM
  • Siemens Healthcare GmbH
  • Intel Corporation
  • GE HealthCare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • ConcertAI
  • Median Technologies
  • PathAI
Product Code: PM4153

The global AI in oncology market size is expected to reach USD 16.72 billion by 2032, according to a new study by Polaris Market Research. The report "AI in oncology Market Share, Size, Trends, Industry Analysis Report, By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Treatment Type, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is poised for substantial growth due to the rising incidence of cancer, driving the demand for technologically advanced products for cancer diagnosis, treatment, and analysis. For instance, the International Agency for Research on Cancer (IARC) estimates over 20.7 million new cases, in 2023. Furthermore, AI plays a crucial role in early detection, contributing to mortality reduction, particularly through effective screening programs.

AI is revolutionizing the field of oncology by leveraging vast datasets generated through multi-omics analyses, coupled with advancements in deep learning and high-performance computing. This integration of AI into oncology encompasses novel approaches for various stages of cancer management, including detection, screening, diagnosis, and classification. AI is instrumental in characterizing cancer genomics, analyzing the tumor microenvironment, assessing prognostic and predictive biomarkers, and formulating strategies for follow-up care and drug discovery. This comprehensive application of AI is enhancing the precision and efficiency of cancer research and treatment.

The rapid progression of technology, particularly in terms of accuracy, safety, and automation, is poised to drive market growth in the foreseeable future. AI, as an emerging and transformative technology, plays a crucial role in significantly increasing screening rates in the field of oncology. Consequently, both public and private organizations are directing their focus towards substantial funding and investment in research and development (R&D) initiatives aimed at advancing AI-based oncology screening products.

For instance, in March 2023, Artera secured funding of nearly, USD 90 million. This funding is earmarked for the launch and distribution of the ArteraAI Prostate Test, marking a significant milestone as the first developed test designed to predict therapy outcomes in localized prostate cancer. This illustrates the growing recognition and support for innovative AI-driven solutions in oncology, with the potential to enhance screening efficiency and therapeutic decision-making.

Key industry players are strategically engaging in collaborations and partnerships, with a primary emphasis on the development of innovative products aimed at facilitating early cancer diagnosis, addressing increasing demand, and advancing research and development pipelines. For instance, in December 2022, AstraZeneca initiated a collaboration with Clinithink to embark on an AI project focused on lung cancer. The primary objective of this project is the early detection of lung cancer, thereby contributing to the formulation of more effective treatment strategies.

AI in Oncology Market Report Highlights

Software solutions segment held the largest share, primarily due to adoption of AI based services for better clinical outcomes

Brain tumor segment expected to grow at the fastest rate, owing to rising cases of brain tumors and huge unmet medical needs

North America dominated the market, as the region has better healthcare infrastructure, coupled with AI players offering healthcare solutions

The global players include Azra AI, IBM, Siemens Healthcare, Intel, GE HealthCare, NVIDIA, Digital Diagnostics, ConcertAI, Median Technologies, and PathAI

Polaris Market Research has segmented the AI in oncology market report based on component, cancer type, treatment type, and region:

AI in Oncology, Component Outlook (Revenue - USD Billion, 2019 - 2032)

  • Software Solutions
  • Hardware
  • Services

AI in Oncology, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others

AI in Oncology, Treatment Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Chemotherapy
  • Radiotherapy
  • Immunotherapy
  • Others

AI in Oncology, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Oncology Market Insights

  • 4.1. AI in Oncology Market - Treatment Type Snapshot
  • 4.2. AI in Oncology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of cancer
      • 4.2.1.2. Treatment Optimization
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy and Security Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. AI in Oncology Market Treatment Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global AI in Oncology Market, by Cancer Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • 5.3. Breast Cancer
    • 5.3.1. Global AI in Oncology Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 5.4. Lung Cancer
    • 5.4.1. Global AI in Oncology Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 5.5. Prostate Cancer
    • 5.5.1. Global AI in Oncology Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
  • 5.6. Colorectal Cancer
    • 5.6.1. Global AI in Oncology Market, by Colorectal Cancer, by Region, 2019-2032 (USD Billion)
  • 5.7. Brain Tumor
    • 5.7.1. Global AI in Oncology Market, by Brain Tumor, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global AI in Oncology Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global AI in Oncology Market, by Component

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 6.3. Software Solutions
    • 6.3.1. Global AI in Oncology Market, by Software Solutions, by Region, 2019-2032 (USD Billion)
  • 6.4. Hardware
    • 6.4.1. Global AI in Oncology Market, by Hardware, by Region, 2019-2032 (USD Billion)
  • 6.5. Services
    • 6.5.1. Global AI in Oncology Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global AI in Oncology Market, by Treatment Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.3. Chemotherapy
    • 7.3.1. Global AI in Oncology Market, by Chemotherapy, By Region, 2019-2032 (USD Billion)
  • 7.4. Radiotherapy
    • 7.4.1. Global AI in Oncology Market, by Radiotherapy, By Region, 2019-2032 (USD Billion)
  • 7.5. Immunotherapy
    • 7.5.1. Global AI in Oncology Market, by Immunotherapy, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global AI in Oncology Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global AI in Oncology Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. AI in Oncology Market - North America
    • 8.3.1. North America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.3.4. AI in Oncology Market - U.S.
      • 8.3.4.1. U.S.: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.3.5. AI in Oncology Market - Canada
      • 8.3.5.1. Canada: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.4. AI in Oncology Market - Europe
    • 8.4.1. Europe: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.4. AI in Oncology Market - UK
      • 8.4.4.1. UK: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.5. AI in Oncology Market - France
      • 8.4.5.1. France: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.6. AI in Oncology Market - Germany
      • 8.4.6.1. Germany: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.7. AI in Oncology Market - Italy
      • 8.4.7.1. Italy: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.8. AI in Oncology Market - Spain
      • 8.4.8.1. Spain: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.9. AI in Oncology Market - Netherlands
      • 8.4.9.1. Netherlands: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.4.10. AI in Oncology Market - Russia
      • 8.4.10.1. Russia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.5. AI in Oncology Market - Asia Pacific
    • 8.5.1. Asia Pacific: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.4. AI in Oncology Market - China
      • 8.5.4.1. China: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.5. AI in Oncology Market - India
      • 8.5.5.1. India: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.6. AI in Oncology Market - Malaysia
      • 8.5.6.1. Malaysia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.7. AI in Oncology Market - Japan
      • 8.5.7.1. Japan: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.8. AI in Oncology Market - Indonesia
      • 8.5.8.1. Indonesia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.5.9. AI in Oncology Market - South Korea
      • 8.5.9.1. South Korea: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.6. AI in Oncology Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.4. AI in Oncology Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.5. AI in Oncology Market - UAE
      • 8.6.5.1. UAE: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.6. AI in Oncology Market - Israel
      • 8.6.6.1. Israel: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.6.7. AI in Oncology Market - South Africa
      • 8.6.7.1. South Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • 8.7. AI in Oncology Market - Latin America
    • 8.7.1. Latin America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.4. AI in Oncology Market - Mexico
      • 8.7.4.1. Mexico: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.5. AI in Oncology Market - Brazil
      • 8.7.5.1. Brazil: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
    • 8.7.6. AI in Oncology Market - Argentina
      • 8.7.6.1. Argentina: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: AI in Oncology Market, by Component, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Azra AI
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. IBM
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Siemens Healthcare GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Intel Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. GE HealthCare
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. NVIDIA Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Digital Diagnostics Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. ConcertAI
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Median Technologies
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. PathAI
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 2 Global AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 3 Global AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 4 AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 6 North America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 7 North America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 10 U.S.: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 11 Canada: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 12 Canada: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 13 Canada: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 Europe: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 15 Europe: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 16 Europe: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 17 UK: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 18 UK: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 19 UK: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 20 France: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 21 France: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 22 France: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 23 Germany: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 24 Germany: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 25 Germany: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 Italy: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 27 Italy: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 28 Italy: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 29 Spain: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 30 Spain: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 31 Spain: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 34 Netherlands: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 35 Russia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 36 Russia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 37 Russia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 41 China: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 42 China: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 43 China: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 44 India: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 45 India: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 46 India: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 49 Malaysia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Japan: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 51 Japan: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 52 Japan: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 55 Indonesia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 58 South Korea: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 65 UAE: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 66 UAE: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 67 UAE: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 68 Israel: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 69 Israel: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 70 Israel: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 73 South Africa: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 76 Latin America: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 79 Mexico: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 82 Brazil: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: AI in Oncology Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: AI in Oncology Market, by Component, 2019-2032 (USD Billion)
  • Table 85 Argentina: AI in Oncology Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global AI in Oncology Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Component
  • Figure 7. Global AI in Oncology Market, by Component, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Cancer Type
  • Figure 9. Global AI in Oncology Market, by Cancer Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Treatment Type
  • Figure 11. Global AI in Oncology Market, by Treatment Type, 2022 & 2032 (USD Billion)
  • Figure 12. AI in Oncology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - AI in Oncology Market